Access to anti-retroviral drugs, male in South Sudan

South Sudan: Access to anti-retroviral drugs, male was 52.0% in 2024. ◆ Volatile

Latest (2024)
52.0%
Change on year
up 13.0%
World rank
113th
of 141 countries
All-time high
52.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in South Sudan, 2000–2024

02040602000201220242000: 0 %2001: 0 %2002: 0 %2003: 0 %2004: 0 %2005: 0 %2006: 0 %2007: 0 %2008: 0 %2009: 1 %2010: 2 %2011: 2 %2012: 3 %2013: 4 %2014: 6 %2015: 9 %2016: 11 %2017: 17 %2018: 21 %2019: 25 %2020: 29 %2021: 31 %2022: 39 %2023: 46 %2024: 52 %

Source: UNAIDS estimates. Measured in %.

Analysis

The most recent figure for access to anti-retroviral drugs, male in South Sudan is 52.0%, measured in 2024. That is the highest value across all 25 years on record.

The figure is up 13.0% on the previous year and up 766.7% over ten years.

Over the whole period, access to anti-retroviral drugs, male in South Sudan peaked at 52.0% in 2024 and was at its lowest, 0.0%, in 2000.

That places South Sudan 113th out of 141 countries with data for 2024, putting it in the bottom quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, male in South Sudan, year by year

Annual values for Access to anti-retroviral drugs, male (%) in South Sudan, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 0.0%
2005 0.0%
2006 0.0%
2007 0.0%
2008 0.0%
2009 1.0%
2010 2.0% +100.0%
2011 2.0% +0.0%
2012 3.0% +50.0%
2013 4.0% +33.3%
2014 6.0% +50.0%
2015 9.0% +50.0%
2016 11.0% +22.2%
2017 17.0% +54.5%
2018 21.0% +23.5%
2019 25.0% +19.0%
2020 29.0% +16.0%
2021 31.0% +6.9%
2022 39.0% +25.8%
2023 46.0% +17.9%
2024 52.0% +13.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 0.1% 0.0% 1.0% 10
2010s 10.0% 2.0% 25.0% 10
2020s 39.4% 29.0% 52.0% 5

Countries ranked near South Sudan

  1. 110 Niger 56.0% compare
  2. 110 Senegal 56.0% compare
  3. 112 Bahrain 53.0% compare
  4. 113 Angola 52.0% compare
  5. 113 Armenia 52.0% compare
  6. 116 Latvia 51.0% compare

See the full ranking of 160 places →

More gender data for South Sudan

All data for South Sudan →

Frequently asked questions

What is access to anti-retroviral drugs, male in South Sudan?
Access to anti-retroviral drugs, male in South Sudan was 52.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in South Sudan?
The highest recorded value was 52.0% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in South Sudan?
The lowest recorded value was 0.0% in 2000.
How does South Sudan rank for access to anti-retroviral drugs, male?
South Sudan ranks 113th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in South Sudan?
Over the last ten years it is up 766.7%. The long-run trend across the full record is volatile.
Where does this South Sudan data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in South Sudan. Statizoid, drawing on UNAIDS estimates. Retrieved 12 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/south-sudan/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/south-sudan/">Access to anti-retroviral drugs, male in South Sudan</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.